Related by context. Frequent words. (Click for all words.) 66 BIO InvestorForum 64 Breast Cancer Symposium 64 AACR NCI EORTC 64 annual Transcatheter Cardiovascular 63 Windhover Information 63 Stem Cell Summit 61 ARVO 61 ICAAC 61 OneMedForum 60 NanoBusiness 60 CONNECTIONS TM 60 Transcatheter Cardiovascular Therapeutics TCT 60 Biomarker Discovery 59 ASCO Annual Meeting 59 CROI 59 Digestive Disease Week DDW 58 Digestive Disease Week 58 Autoimmunity 58 Annual BIO 58 AACR 58 Cancer Therapeutics 58 AASLD 58 CONNECTIONS ™ 57 Chemotherapy ICAAC 57 Retroviruses 57 Molecular Targets 57 Alzheimer Disease ICAD 57 AACR Annual Meeting 57 Biotech Showcase 56 Antimicrobial Agents 56 Drug Discovery 56 Molecular Diagnostics 56 EuroPCR 56 JMP Securities Healthcare 56 NASDAQ ARIA 56 SupplySide West 56 BIOTECHNICA 56 ENDO 56 Genaera Corporation 56 Antisense 56 EORTC NCI AACR Symposium 56 Bioprocessing 56 Annual Scientific Sessions 56 & Renshaw Techvest 55 Vicor Technologies 55 Biogen Idec NASDAQ BIIB 55 Tissue Engineering 55 Chemokine Therapeutics 55 Response Genetics 55 SEQUENOM 55 INTERPHEX 55 Epizyme 55 Genedata 55 Endovasc 55 BIO 55 Regulus Therapeutics 55 Idenix Pharmaceuticals 54 Oral Presentation 54 Poster Presentation 54 ESBATech 54 therapeutic monoclonal antibodies 54 Next Generation Sequencing 54 Monoclonal Antibodies 54 Medtech Insight 54 Bioprocess 54 Rexahn Pharmaceuticals 54 Molecular Cancer 54 Chronix 54 BIO Investor 54 CleanEquity Monaco 54 Cempra 54 M2M Evolution 54 In3 54 Neuro Oncology 54 Small Molecule 54 Merrimack Pharmaceuticals 54 IntertechPira 54 Hana Biosciences 54 Personalized Medicine 53 Infinity Pharmaceuticals 53 Drug Pipeline 53 BioSpecifics Technologies Corp. 53 Genitope Corporation 53 GridWeek 53 Pacific Biometrics 53 Idera Pharmaceuticals 53 OXIS International 53 Angiogenesis 53 Hematology Annual Meeting 53 ESMO 53 Cellular Therapy 53 Clinical Oncology Annual Meeting 53 Sunesis Pharmaceuticals Inc. 53 Response Genetics Inc. 53 BioCentury 53 PsychoGenics 53 Array BioPharma 53 NanoViricides 53 Controlled Release 53 DVCon 53 Crucell NV Euronext